CLINICAL QUALITY MEASURES Public Reports

CLINICAL QUALITY MEASURES Public Reports

Table of Contents

Introduction...................................................................................................................................... 4 Measures Summary .......................................................................................................................... 5 Reports by Measure .......................................................................................................................... 6

ASM ? Appropriate Medications for People with Persistent Asthma ............................................................6 AWC ? Adolescent Well-Care Visits .............................................................................................................7 BCS ? Breast Cancer Screening ....................................................................................................................8 CCS ? Cervical Cancer Screening ..................................................................................................................9 CHL ? Chlamydia Screening ....................................................................................................................... 10 CM1 ? LDL-C Screening for Patients with Cardiovascular Conditions...........................................................11 CM3 ? LDL-C Control for Patients with Cardiovascular Conditions .............................................................. 12 COL ? Colorectal Cancer Screening ............................................................................................................ 13 CWP ? Appropriate Testing for Children with Pharyngitis .......................................................................... 14 DC1 ? HbA1c Testing for Patients with Diabetes ........................................................................................ 15 DC2 ? HbA1c Controlled at 9% for Patients with Diabetes ........................................................................ 16 DC3 ? LDL-C Testing for Patients with Diabetes ......................................................................................... 17 DC5 ? LDL-C Controlled at ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download